Effective Tuesday, October 21, 2025, the NCIP is transitioning RSV vaccine ordering from the Smartsheet Request Form to the North Carolina Immunization Registry (NCIR).
Note: All orders previously placed through Smartsheet have been processed.
Please monitor your inventory and maintain sufficient stock to meet the needs of Vaccines for Children (VFC)-eligible patients throughout the 2025–2026 respiratory season.
Dear Local Health Departments,
On Oct. 6, 2025, the Acting CDC Director approved the Advisory Committee on Immunization Practices (ACIP) COVID-19 vaccine recommendations. The CDC has updated its adult and child immunization schedules to apply individual-based decision-making to COVID-19 vaccination for 6 months and older, after consultation with a health care provider.
North Carolina Vaccines for Children (VFC) providers can now order the pentavalent meningococcal (A,B,C,W, and Y) vaccine, PENMENVY™ (NDC 58160-757-15) via NCIR for administration to their VFC-eligible adolescents (ages 10 through 18 years).
This email is to inform you that the North Carolina Immunization Program (NCIP) has opened applications for birthing hospitals interested in participating in the replacement model for birth dose Hepatitis B and RSV.
The purpose of this email is to inform VFC-enrolled providers that the RSV monoclonal antibody product clesrovimab (trade name ENFLONSIA™ manufactured by Merck) is now available for ordering. VFC doses will begin shipping after Oct. 2, 2025.
Clesrovimab UseClesrovimab is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants under 8 months of age who are born during or entering their first RSV season and who are not protected through maternal RSV vaccination.
Download The 2025 LHD Annual Immunization Assessment Memo
The purpose of this memo is to remind local health department (LHD) staff about the upcoming 2025 Annual Immunization Assessment. This assessment will review NCIR records of children, 24 through 35 months old, who are labeled "active" in NCIR under the LHD site, as well as all children that live in the county.
Dear Local Health Department Partner,
This email is to inform you that the North Carolina Immunization Program (NCIP) has doses of 317 VFA ABRYSVO® vaccine available for order for non-Medicaid, uninsured pregnant women between 32 to 36 weeks of gestation during September through January, who are receiving services at the local health department.
ABRYSVO® administrations to pregnant individuals began on September 1, 2025, for the current RSV season.
Dear Local Health Departments,
On Wednesday, Aug. 27, 2025, FDA approved the updated 2025-2026 COVID-19 vaccines and rescinded Emergency Use Authorizations (EUA) for previously authorized COVID-19 vaccines.